Skip to main content
Clinical Trials/ACTRN12605000310662
ACTRN12605000310662
Completed
Not Applicable

The potential of selenium supplements via enriched dairy foods to improve bowel health and reduce risk of colon cancer in humans

Flinders Medical Centre0 sites15 target enrollmentSeptember 6, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bowel Cancer
Sponsor
Flinders Medical Centre
Enrollment
15
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 6, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Participants will be healthy, with no active bowel disease, or a previous history of adenoma removal \>6 months ago, with plasma selenium at or below 95ug/dL.

Exclusion Criteria

  • Any allergy or intolerance to milk/dairy products plasma Se above the 95th percentile of the current population (i.e. \>95ug/dl), evidence of any active mucosal bowel disease, eg colitis, or of malabsorption, no evidence of any other active clinical disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials